American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Perales
    Perales
  5. Tallman
    Tallman
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Palomba
    Palomba
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)
  7. Bone Marrow Transplant (988)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (955)
  9. Lymphoma (941)
  10. Tow Center for Developmental Oncology (TCDO) (882)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1257)
  3. Research Letter (46)
  4. Review (44)
  5. Editorial (35)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)

More Groups

People
  1. Sergio Giralt (348)
  2. Andrew Zelenetz (341)
  3. Ross Levine (316)
  4. Miguel-Angel Perales (312)
  5. Martin Tallman (301)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (64)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5174)
  2. Blood Advances (331)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5555)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I trial of a pharmacodynamically-conceived decitabine and thioguanine combination in patients with advanced myeloid malignancies
    Meeting Abstract

    Rosenblat, T.; Heaney, M. L.; Jurcic, J. G.; Raza, A.; Mears, J. G.; Santos, R.; Carrillo, D.; Shum, D.; Gonzales, J.; Zikaras, K.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Updated results from a large, ongoing, treatment IND study using defibrotide for patients with hepatic veno-occlusive disease
    Meeting Abstract

    Richardson, P. G.; Smith, A. R.; Triplett, B. M.; Kernan, N. A.; Grupp, S. A.; Arai, S.; Antin, J. H.; Lehmann, L. E.; Bandiera, V.; Hume, R. L.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Defibrotide for the treatment of severe hepatic veno-occlusive disease: An analysis of clinical benefit as determined by number needed to treat (NNT) to achieve complete response and to improve survival
    Meeting Abstract

    Richardson, P. G.; Kernan, N. A.; Grupp, S. A.; Martin, P. L.; Soiffer, R. J.; Martin, R.; Hannah, A. L.; Villa, K. F.
    Blood (2014)

    Fulltext@MSK | Save
  • Improved survival in patients with first relapsed or refractory acute myeloid leukemia (AML) treated with vosaroxin plus cytarabine versus placebo plus cytarabine: Results of a phase 3 double-blind randomized controlled multinational study (VALOR)
    Meeting Abstract

    Ravandi, F.; Ritchie, E.; Sayar, H.; Lancet, J.; Craig, M. D.; Vey, N.; Strickland, S. A.; Schiller, G.; Jabbour, E.; Erba, H. P.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid lukemia
    Meeting Abstract

    Rampal, R. K.; Alkalin, A.; Madzo, J.; Vasanthakumar, A.; Pronier, E.; Patel, J. P.; Li, Y. S.; Ahn, J.; Abdel-Wahab, O.; Shih, A. H.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • AMC075: The combination of vorinostat with chemotherapy and rituximab is tolerable and feasible in HIV-related B-cell non-Hodgkin's lymphoma with high-risk features
    Meeting Abstract

    Ramos, J. C.; Sparano, J.; Moore, P.; Lee, J. Y.; Rudek, M. A.; Ambinder, R. F.; Cesarman, E.; Noy, A.; Mitsuyasu, R. T.
    Blood (2014)

    Fulltext@MSK | Save
  • Engineered T cell receptor-mimic antibody, (TCRm) chimeric antigen receptor (CAR) T cells against the intracellular protein Wilms tumor-1 (WT1) for treatment of hematologic and solid cancers
    Meeting Abstract

    Rafiq, S.; Dao, T.; Liu, C.; Scheinberg, D. A.; Brentjens, R. J.
    Blood (2014)

    Fulltext@MSK | Save
  • T cells in CTCL have an exhausted phenotype while cutaneous dendritic cells display a normally activated mature phenotype
    Meeting Abstract

    Querfeld, C.; Curran, S. A.; Leung, S.; Myskowski, P. L.; Horwitz, S. M.; Halpern, A. C.; Young, J. W.
    Blood (2014)

    Fulltext@MSK | Save
  • Day 45 lymphocyte recovery is independently associated with transplant-related mortality after adult myeloablative double-unit cord blood transplantation (dCBT)
    Meeting Abstract

    Purtill, D.; Ponce, D. M.; Devlin, S. M.; Lubin, M. N.; Dahi, P. B.; Giralt, S. A.; Perales, M. A.; O'Reilly, R. J.; van den Brink, M. R. M.; Young, J. W.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Analysis of 129 myeloablative double-unit cord blood transplantation recipients demonstrates an independent association between non-dominant unit TNC dose and engraftment suggesting a facilitation effect
    Meeting Abstract

    Purtill, D.; Lubin, M. N.; Ponce, D. M.; Giralt, S.; Perales, M. A.; O'Reilly, R. J.; Van Den Brink, M.; Young, J. W.; Scaradavou, A.; Stevens, C.; more...
    Blood (2014)

    Fulltext@MSK | Save